These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7595548)

  • 61. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from 7315c cell membranes.
    Cote TE; Gosse ME; Weems HB
    J Neurochem; 1993 Sep; 61(3):973-8. PubMed ID: 8395567
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR; Clark MJ; Remmers AE
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.
    Wang HL
    J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
    Chan JS; Chiu TT; Wong YH
    J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study.
    Takita K; Herlenius EA; Lindahl SG; Yamamoto Y
    Brain Res; 1997 Dec; 778(1):233-41. PubMed ID: 9462896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F; Lawrence AJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3).
    Chalecka-Franaszek E; Weems HB; Crowder AT; Cox BM; Côté TE
    J Neurochem; 2000 Mar; 74(3):1068-78. PubMed ID: 10693938
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay.
    Romero DV; Partilla JS; Zheng QX; Heyliger SO; Ni Q; Rice KC; Lai J; Rothman RB
    Synapse; 1999 Nov; 34(2):83-94. PubMed ID: 10502307
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.
    Gioannini TL; Onoprishvili I; Hiller JM; Simon EJ
    Neurochem Res; 1999 Jan; 24(1):37-42. PubMed ID: 9973235
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coupling of multiple opioid receptors to GTPase following selective receptor alkylation in brain membranes.
    Clark MJ; Medzihradsky F
    Neuropharmacology; 1987 Dec; 26(12):1763-70. PubMed ID: 2830555
    [TBL] [Abstract][Full Text] [Related]  

  • 78. G-receptor antagonists increased the activating effect of mastoparan on low Km GTPase of mouse PAG.
    Martínez-Peña Y; Sánchez-Blázquez P; Garzón J
    Cell Signal; 1995 Feb; 7(2):151-5. PubMed ID: 7794687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of zonal centrifugation method for the preparation of mu-opioid receptor enriched membranes from bovine corpus striatum.
    Sastry KV; Harikumar KG; Sailaja P; Janardana Sarma MK
    J Neurosci Methods; 1997 Jun; 74(1):45-52. PubMed ID: 9210574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Purification of opioid receptor in the presence of sodium ions.
    Li LY; Zhang ZM; Su YF; Watkins WD; Chang KJ
    Life Sci; 1992; 51(15):1177-85. PubMed ID: 1326689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.